Breaks Categories: News

TuesdayApr 10, 2018 9:30 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Achieved Monthly Sales Record in March

Cannabidiol-focused holding company PotNetwork Holding Inc. (OTC: POTN) this morning announced its record-breaking sales performance for March 2018. Notably, the company recorded over $2.2 million in sales revenue for the month, marking a year-over-year increase of 152 percent. These results continue to build on what has been a strong start to 2018 for PotNetwork Holding. With over $6.3 million in revenues recorded during the first quarter, the company is well positioned to exceed its 2017 performance, which included sales of $14.5 million and gross profits of nearly $5.2 million. PotNetwork Holding’s strong start to 2018 has been solidified by the…

Continue Reading

TuesdayApr 10, 2018 9:21 am

NetworkNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRA: 6F6) (WKN: A2AKL8) Enters Definitive Agreement to Acquire Limitless Blockchain Technology, LLC.

Blockchain-focused venture builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced that it will acquire all issued and outstanding membership interests of Limitless Blockchain Technology, LLC for $5,000,000 Canadian in total consideration, subject to all requisite regulatory approvals. Per the terms of the definitive share purchase agreement executed between the company and the interest owner of Limitless Blockchain, the purchase price will be paid by Victory Square through the issuance of 3,703,703 common shares in the capital of the company at a price of $1.35 Canadian each. The shares will be subject to…

Continue Reading

MondayApr 09, 2018 1:48 pm

NetworkNewsBreaks – American-Swiss Capital Files Form S-1 for Proposed IPO

American-Swiss Capital, Inc. announced today that it has officially filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") related to its proposed initial public offering ("IPO"). According to the press release, the company will be applying for quotation of its stock on the OTCQB tier of the OTC Markets Group, Inc. Marketplace. To view the Form S-1 filing and learn more about American-Swiss Capital, visit http://nnw.fm/cX7xh About American-Swiss Capital, Inc. American-Swiss Capital, Inc. is focused on identifying profitable real estate investment opportunities designed to generate a high rate of return on investment. The Company…

Continue Reading

MondayApr 09, 2018 1:00 pm

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Schedules 2018 Annual Meeting; Announces Non-Brokered Private Placement

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced a non-brokered private placement of up to 16 million units at the price of $0.25 per unit for total gross proceeds of up to CAD$4,000,000. Each unit is comprised of one common share of the company and one warrant with an exercise price of $0.50 per share for a period of 24 months from the closing of the offering. The units are subject to an acceleration provision that enables sooner expiration of the warrants if the closing price of the shares on the Canadian Securities Exchange…

Continue Reading

MondayApr 09, 2018 12:01 pm

NetworkNewsBreaks – Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) Enters Agreement to Acquire Robinson’s Cannabis Inc.

Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) this morning announced that it has entered into a share purchase agreement with Robinson's Cannabis Inc. to acquire all of the issued and outstanding shares of Robinson's. Robinson's is a privately-owned licensed producer applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") that has completed Health Canada’s paper-based review process and is currently in the confirmation of readiness stage. Per the terms of the share purchase agreement, the company will acquire all of the issued and outstanding shares of Robinson's. Upon the completion of the acquisitions, which is subject to…

Continue Reading

MondayApr 09, 2018 9:14 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary to Participate at 2018 Telecom Review Summit

PotNetwork Holding, Inc. (OTC: POTN), through wholly owned subsidiary Diamond CBD Inc., this morning announced its participation at the 2018 Telecom Review Summit held in Beirut, Lebanon. The event, which is scheduled to take place on April 13, 2018, will feature a keynote panel, hosted by Exponential, Inc. (“XPO2”) founder and CEO Dom Einhorn, focused on the importance of corporate responsibility and impact investing, including how these corporate values can strengthen brand recognition and lead to the development of new sales channels. Notably, Diamond CBD recently announced its entry into an exclusive affinity marketing campaign with XPO2. Dr. Richard Goulding,…

Continue Reading

FridayApr 06, 2018 12:57 pm

NetworkNewsBreaks – Xanthic Biopharma Inc. Receives Conditional Listing Approval from the CSE

Xanthic Biopharma, a premium cannabinoid life sciences and technology company, recently announced that it has been granted conditional listing approval from the Canadian Securities Exchange (“CSE”) to list its common shares under the ticker symbol xTHC. The listing is subject to the successful completion of customary listing requirements of the CSE. The company has requested April 19th as its first trading date. “We are thrilled to begin trading on the CSE especially on the eve of ‘4/20’. We are excited to have obtained the ticker symbol xTHC, which we feel is memorable and readily connected with “Xanthic”. Our team would…

Continue Reading

FridayApr 06, 2018 10:00 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Management Discusses Bitcoin Cannabis Payments App on MoneyTV

Specialized holding company SinglePoint, Inc. (OTCQB: SING) this morning announced it is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” In this week’s episode, members of Singlepoint’s management team, including CEO Greg Lambrecht and President Wil Ralston, discuss the company’s current and future endeavors in the converging cannabis and cryptocurrency markets. Highlights from the episode include Lambrecht’s view on the milestones SinglePoint has achieved to date and Ralston’s update regarding the development of the company’s bitcoin cannabis payments app. “2018 I think…

Continue Reading

ThursdayApr 05, 2018 2:52 pm

NetworkNewsBreaks – Reliq Health Technologies Inc. (TSXV: RHT) (OTCQB: RQHTF) Expands Paz Home Health Contract in Texas

Reliq Health Technologies (TSXV: RHT) (OTCQB: RQHTF), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, this morning said it has expanded its contract with Paz Home Health LLC in Texas to provide its iUGO Care remote patient monitoring and telemedicine solution. The contract revision surges the number of Paz Home Health subscribers to over 15,000 patients total and is expected to generate over $9 million in annual recurring revenue after reaching full deployment by Q4 2018. “We are excited to announce that as a result of their implementation of the iUGO…

Continue Reading

ThursdayApr 05, 2018 12:30 pm

NetworkNewsBreaks – BriaCell Therapeutics Corp.’s (TSX-V: BCT) (OTCQB: BCTXF) Lead Product Candidate Highlighted in Frontiers in Immunology Publication

BriaCell Therapeutics (TSX-V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, recently announced that a manuscript highlighting the company’s lead product candidate, Bria-IMT™, was published in Frontiers in Immunology. The manuscript describes the novel mechanism of action of Bria-IMT™ as well as encouraging clinical results observed in current and past clinical testing, including the notable reduction of tumor size in some patients with advanced metastatic breast cancer. The publication provides evidence for the unique immune-enhancing activity, which is believed to set the Bria-IMT™ approach apart from comparable therapies. “Our investigations into the mechanism of…

Continue Reading